<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:HZNP (Ireland) Also Trade In: Germany

Horizon Therapeutics PLC $ 27.49 -1 (-3.49%)

Volume:
644,720
Avg Vol (1m):
1,356,199
Market Cap $:
5.11 Bil
Enterprise Value $:
5.60 Bil
P/E (TTM):
63.77
P/B:
3.34
Warning! GuruFocus has detected 2 Severe warning signs with HZNP. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

HZNP News and Headlines - Horizon Therapeutics PLC

GuruFocus Articles Total 32
  • 1
  • 2

Chairman, President and CEO of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Timothy P Walbert (insider trades) sold 320,174 shares of HZNP on 10/15/2019 at an average price of $28.02 a share. The total sale was $9 million.

Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics PLC has a market cap of $5.31 billion; its shares were traded at around $28.48 with a P/E ratio of 66.27 and P/S ratio of 3.89. GuruFocus has detected 2

0 Views    [email protected]    2019-10-17 21:15
Investment company Polianta Ltd (Current Portfolio) buys Vanguard REIT ETF, Vanguard Financials ETF, iShares U.S. Telecommunications ETF, First Trust ISE Water Index Fund, Vanguard Value ETF, sells SPDR EURO STOXX 50 ETF, iShares MSCI EMU ETF, iShares S&P 100 ETF, iShares MSCI France ETF, iShares MSCI Spain Capped ETF during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Polianta Ltd. As of 2019Q3, Polianta Ltd owns 63 stocks with a total value of $140 million. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-09 17:38
Horizon's drug for thyroid eye disease could replace invasive surgery for many and bring in $750 million annually

If faced with the choice between invasive surgery versus a few shots, most would probably choose the latter, ophthalmologists included. Patients with bulging eyes from thyroid eye disease may finally have a long-term solution for their eye predicament in new injections specifically designed to alleviate the cause of the disease. And it looks as though the company behind it, Horizon Pharma (HZNP), may end up having the whole market to itself for a while.

It’s not a particularly huge market, but with 12 years of exclusivity ahead, nearly flawless efficacy and safety results showing fast action and no close competitors

36 Views    Matt Winkler    2019-04-29 16:36

NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of The Goodyear Tire & Rubber Company (GT), Cars.com Inc. (:CARS), Tutor Perini Corporation (:TPC), CVS Health Corporation (:CVS), VMware, Inc. (:VMW), and Horizon Pharma Public Limited Company (HZNP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers

0 Views    Marketwired    2019-03-05 17:03

NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern Company (:SO), Horizon Pharma Public Limited Company (HZNP), Celestica, Inc. (:CLS), RCI Hospitality Holdings, Inc. (RICK), Bluerock Residential Growth REIT, Inc. (:BRG), and Tilly's, Inc. (:TLYS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at

0 Views    Marketwired    2019-02-04 13:01

NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mammoth Energy Services, Inc. (TUSK), Horizon Pharma Public Limited Company (HZNP), SBA Communications Corporation (SBAC), International Flavors & Fragrances, Inc. (:IFF), WillScot Corporation (WSC), and Teekay Tankers Ltd. (:TNK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to

0 Views    Marketwired    2018-11-29 13:03

NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Endeavour Silver Corporation (:EXK), Triton International Limited (:TRTN), Resonant Inc. (RESN), Radware Ltd. (RDWR), Horizon Pharma Public Limited Company (HZNP), and Ensco plc (:ESV), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2018-10-19 16:02

-- New insights on the factors associated with tophi formation and total body disease burden of gout --

DUBLIN, Ireland, June 15, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) presents multiple analyses of KRYSTEXXA® (pegloticase injection) clinical trial data underscoring the complex nature of chronic gout refractory to conventional therapies, also known as uncontrolled gout.  The data are being presented in oral and poster sessions at the Annual European Congress of Rheumatology (EULAR 2018), June 13 -16, 2018.

“These data presented at EULAR demonstrate how

0 Views    Marketwired    2018-06-15 12:00

-- New insights on the factors associated with tophi formation and total body disease burden of gout --

DUBLIN, Ireland, June 15, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) presents multiple analyses of KRYSTEXXA® (pegloticase injection) clinical trial data underscoring the complex nature of chronic gout refractory to conventional therapies, also known as uncontrolled gout.  The data are being presented in oral and poster sessions at the Annual European Congress of Rheumatology (EULAR 2018), June 13 -16, 2018.

“These data presented at EULAR demonstrate how elevated serum uric

3 Views    GlobeNewswire    2018-06-15 10:00

-- Results reflect the undermanaged burden of uncontrolled gout --

AMSTERDAM, The Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- Results from a new study presented in an oral presentation at the Annual European Congress of Rheumatology (EULAR 2018) show a dramatic 27 percent increase in emergency department (ED) visits between 2006 and 2014 for people living with gout in the United States.  Horizon Pharma provided research support and funding for this study.

"The dramatic increase in ED visits in the United States for patients

0 Views    Marketwired    2018-06-14 12:01

NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Horizon Pharma Public Limited Company (HZNP), Lululemon Athletica, Inc. (LULU), Nordic American Tankers Limited (:NAT), UBS Group AG (:UBS), 21Vianet Group, Inc. (VNET), and Sandstorm Gold, Ltd. (:SAND), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at

0 Views    Marketwired    2018-06-07 12:01

-- People can join the campaign by texting the word “RARE” to 56512, which generates a donation to NORD --

DUBLIN, Ireland, June 04, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) and the National Organization for Rare Disorders (NORD) today launched a new campaign recognizing rare disease innovation since the passing of the Orphan Drug Act in 1983.  Beginning today in the main lobby of the 2018 Biotechnology Innovation Organization (BIO) International Convention in Boston, innovators from throughout the world can view the creation of a work

0 Views    Marketwired    2018-06-04 12:03

PR Newswire

CHICAGO, May 31, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AEO, HZNP, MU, and VSTM.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy a link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring

1 Views    PRNewswire    2018-05-31 16:06

DUBLIN, Ireland, May 30, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP), today announced that the company will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 and will present at 10:40 a.m. PT.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines

0 Views    Marketwired    2018-05-30 16:01

DUBLIN, Ireland, May 22, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) today announced that it has been selected to FORTUNE and Great Place to Work’s 2018 “Best Workplaces in Chicago” list. Horizon ranked number four out of 25 other small and medium sized companies.

“It’s a great honor that FORTUNE and Great Place to Work have again named Horizon Pharma as one of the top workplaces in Chicago,” said Timothy P. Walbert, chairman, president and chief executive officer. “Many of us are

0 Views    Marketwired    2018-05-22 16:03

DUBLIN, Ireland, May 22, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) today marked Gout Awareness Day with the launch of Gout Revealed, which was created to spotlight real-life stories of people living with uncontrolled gout, a painful and debilitating inflammatory form of arthritis caused by too much uric acid in the blood that continues despite the use of oral medicines.  The site features people sharing their experiences with the disease – from the impact of the pain and the moments of life missed,

0 Views    Marketwired    2018-05-22 16:01

Will Represent the Eighth and Ninth U.S. Patents to be Listed in the Orange Book for RAVICTI -

DUBLIN, Ireland, May 08, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) today announced that it has received two Notices of Allowance from the United States Patent and Trademark Office for U.S. patent application numbers 15/457,643 and 15/687,132, both entitled "Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs” that cover Horizon's U.S. approved medicine RAVICTI (glycerol phenylbutyrate) Oral Liquid.

These Notices of Allowance conclude the substantive examination of

0 Views    Marketwired    2018-05-08 16:02

DUBLIN, IRELAND, May 04, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) today announced that the compensation committee of its board of directors approved the grant on May 1, 2018 of inducement restricted stock units for an aggregate of 228,305 ordinary shares to 30 new employees.

Certain of the restricted stock units vest over four years, with 25 percent of the shares vesting on each anniversary of the applicable vesting commencement date, and certain of the restricted stock units vest over three years, with 1/3

0 Views    Marketwired    2018-05-04 12:02

DUBLIN, Ireland, May 03, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP) today announced that Sangita Iyer, director, financial planning and analysis, has been named a 2018 Healthcare Businesswomen's Association (HBA) Rising Star.  Sangita will be honored today at the 29th annual Woman of the Year event in New York.

The HBA is the leading not-for-profit global organization committed to furthering the advancement and impact of women in healthcare worldwide.  Sangita is being recognized for her exemplary leadership, dedication to the healthcare industry, as well as her significant contributions across the

0 Views    Marketwired    2018-05-03 16:05

DUBLIN, IRELAND, May 01, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (HZNP), today announced that the company will participate in the following conference in May:

UBS Global Healthcare Conference

  • Date:  May 22, 2018
  • Presentation Time:  9:30 a.m. ET
  • Location:  New York

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines

0 Views    Marketwired    2018-05-01 16:04

Headlines Total 191
  • 1
  • 2

2019-10-17 $ 28.48 (-0.42%)
4:15pm
2019-10-09 $ 26.32 (0.34%)
12:38pm
2019-09-13 $ 26.34 (-0.34%)
11:59am
2019-09-12 $ 26.43 (-1.05%)
9:02am
2019-09-11 $ 26.71 (0.79%)
9:49am
2019-09-10 $ 26.5 (-0.15%)
6:59am
2019-09-09 $ 26.54 (-2.03%)
2:02pm
2019-09-06 $ 27.09 (1.54%)
8:31am
2019-08-08 $ 27.59 (4.15%)
9:15am
2019-08-07 $ 26.49 (12.01%)
1:46pm
10:38am
7:45am
2019-07-31 $ 24.89 (0.08%)
9:36am
2019-07-19 $ 24.1 (-2.15%)
8:41am
2019-07-11 $ 23.58 (0.47%)
8:05am
2019-05-09 $ 28.48 (0.64%)
5:17pm
2019-05-08 $ 28.3 (4.97%)
1:44pm
1:23pm
10:36am
7:25am
2019-05-07 $ 26.96 (-1.79%)
3:54pm
3:48pm
9:53am
9:47am
8:35am
6:53am
2019-05-06 $ 27.45 (3.43%)
3:13pm
2:06pm
10:54am
10:42am
8:38am
2019-05-03 $ 26.54 (2.12%)
4:22pm
9:32am
2019-05-02 $ 25.99 (0.74%)
3:57pm
9:58am
9:11am
9:02am
2019-05-01 $ 25.8 (1.06%)
5:07pm
9:32am
8:28am
2019-04-30 $ 25.53 (-2.37%)
9:02am
2019-04-29 $ 26.15 (1.28%)
11:36am
7:25am
2019-04-28
3:22pm
2019-04-10 $ 27.12 (%)
9:10am
2019-03-29 $ 26.43 (1.15%)
8:30am
2019-03-11 $ 26.55 (-0.04%)
10:48am
2019-03-08 $ 26.56 (2.87%)
1:36pm
2019-03-05 $ 27.22 (-2.82%)
11:03am
2019-03-04 $ 28.01 (-0.6%)
9:00am
2019-03-01 $ 28.18 (-2.86%)
8:30am
7:00am
2019-02-28 $ 29.01 (32.77%)
4:32pm
12:00pm
11:10am
10:12am
7:58am
2019-02-27 $ 21.85 (4.6%)
1:12pm
11:50am
8:04am
2019-02-20 $ 21.54 (-4.98%)
9:31am
2019-01-30 $ 20.98 (2.64%)
8:11pm
2019-01-15 $ 22.15 (0.96%)
7:37am
2019-01-08 $ 21.36 (0.61%)
1:21pm
2019-01-02 $ 19.93 (2%)
3:28pm
2018-12-28 $ 19.42 (1.73%)
7:29am
2018-12-07 $ 19.65 (-2.04%)
8:30am
2018-12-04 $ 20.25 (-2.03%)
3:13pm
2018-11-08 $ 22.09 (-1.56%)
10:13am
2018-11-07 $ 22.44 (15.97%)
10:26am
10:12am
8:20am
2018-11-05 $ 19.48 (0.93%)
4:39pm
4:32pm
2018-10-31 $ 18.21 (-1.35%)
9:32am
2018-10-28
1:09pm
2018-09-25 $ 19.47 (1.35%)
6:08am
2018-09-07 $ 20.6 (0.39%)
4:31pm
8:30am
2018-09-05 $ 20.95 (-0.29%)
4:34pm
2018-08-24 $ 20.19 (0.2%)
7:36am
2018-08-22 $ 20.39 (-0.54%)
5:22am
2018-08-09 $ 20.91 (3.93%)
8:17am
2018-08-08 $ 20.12 (10.79%)
2:43pm
8:22am
7:50am
2018-08-06 $ 17.99 (0.11%)
10:21am
8:22am
2018-08-02 $ 18.18 (2.6%)
9:24am
2018-07-31 $ 17.63 (0.86%)
9:03am
2018-07-27 $ 17.34 (-2.47%)
10:27am
2018-07-25 $ 17.69 (2.43%)
10:28am
2018-07-23 $ 17.59 (0.74%)
5:33pm
10:06am
9:59am
2018-07-10 $ 16.91 (-1.51%)
8:30am
2018-06-15 $ 17.57 (-0.85%)
7:00am
2018-06-14 $ 17.72 (1.61%)
7:01am
2018-06-08 $ 17.26 (5.63%)
9:13am
2018-06-07 $ 16.34 (0.06%)
7:01am
Total 191
  • 1
  • 2